Skip to main content
Log in

Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly

  • Basic Science • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

Objectives

To explore the prevalence of obstructive sleep apnea (OSA) and the association between the adenoma granulation patterns and OSA in patients with acromegaly.

Methods

An overnight polysomnography (PSG) assessment was carried out on participants with acromegaly. Results classified participants into a non-OSA group, mild to moderate OSA group, and severe OSA group. Morphological and biochemical analyses were performed. Demographic, clinical, biochemical, and polysomnographic data were compared among the three groups. Using logistic regression models, the risk of OSA in acromegalic subjects was estimated.

Results

OSA was reported in 36 of 49 patients (74%) with acromegaly. Contrasted with the non-OSA group, OSA patients had a larger proportion of the densely granulated (DG) pattern. The OSA groups with DG acromegaly had a smaller maximum tumor diameter and Vol/2 than those with the sparsely granulated (SG) pattern. Furthermore, a higher growth hormone (GH) level (45.0 ± 36.9 vs 18.6 ± 15.8, P = 0.047) and GH index (28.4 ± 13.8 vs 6.6 ± 8.2, P = 0.003) were found in DG acromegaly patients with severe OSA. Additionally, there was a trend toward higher standardized insulin-like growth factor 1 (IGF-1) in patients with DG acromegaly than in those with SG acromegaly in the severe OSA group. After adjusting for potential confounding variables, the DG pattern was correlated with the risk of OSA (OR = 14.84, 95%CI 1.36–162.20, P = 0.027) in patients with acromegaly.

Conclusions

The findings indicate that a high prevalence of OSA exists in patients with acromegaly, and the DG pattern may be a risk factor for OSA in acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Melmed S (2006) Acromegaly. N Engl J Med 355(24):2558–2573

    Article  CAS  PubMed  Google Scholar 

  2. Colao A et al (2019) Acromegaly. Nat Rev Dis Primers 5(1):20

    Article  PubMed  Google Scholar 

  3. Guo X et al (2018) Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep Med 48:27–34

    Article  CAS  PubMed  Google Scholar 

  4. Rodrigues MP et al (2008) Craniofacial abnormalities, obesity, and hormonal alterations have similar effects in magnitude on the development of nocturnal hypoxemia in patients with acromegaly. J Endocrinol Invest 31(12):1052–1057

    Article  CAS  PubMed  Google Scholar 

  5. Kashine S et al (2012) Characteristics of sleep-disordered breathing in Japanese patients with acromegaly. Endocr J 59(1):31–38

    Article  PubMed  Google Scholar 

  6. Kaw R et al (2012) Postoperative complications in patients with obstructive sleep apnea. Chest 141(2):436–441

    Article  PubMed  Google Scholar 

  7. Apnea ASOA (2014) Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 120(2):268–286

    Article  Google Scholar 

  8. Franklin KA, Lindberg E (2015) Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis 7(8):1311–1322

    PubMed  PubMed Central  Google Scholar 

  9. Vannucci L et al (2013) Assessment of sleep apnea syndrome in treated acromegalic patients and correlation of its severity with clinical and laboratory parameters. J Endocrinol Invest 36(4):237–242

    CAS  PubMed  Google Scholar 

  10. Castellani C et al (2016) Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients. Endocrine 51(2):308–316

    Article  CAS  PubMed  Google Scholar 

  11. Davi MV, Giustina A (2012) Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev Endocrinol Metab 7(1):55–62

    Article  PubMed  Google Scholar 

  12. Wagenmakers MA et al (2015) Three-dimensional facial analysis in acromegaly: a novel tool to quantify craniofacial characteristics after long-term remission. Pituitary 18(1):126–134

    Article  CAS  PubMed  Google Scholar 

  13. Wolters TLC et al (2020) The course of obstructive sleep apnea syndrome in patients with acromegaly during treatment. J Clin Endocrinol Metab 105(1):290–304

    Article  Google Scholar 

  14. Akirov A et al (2019) The clinicopathological spectrum of acromegaly. J Clin Med 8(11):1962

    Article  CAS  PubMed Central  Google Scholar 

  15. Kiseljak-Vassiliades K et al (2015) Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine 49(1):231–241

    Article  CAS  PubMed  Google Scholar 

  16. Bakhtiar Y et al (2010) Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae. Eur J Endocrinol 163(4):531–539

    Article  CAS  PubMed  Google Scholar 

  17. Fougner SL et al (2012) Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol 76(1):96–102

    Article  CAS  Google Scholar 

  18. Roemmler J et al (2012) Elevated incidence of sleep apnoea in acromegaly—correlation to disease activity. Sleep Breath 16(4):1247–1253

    Article  CAS  PubMed  Google Scholar 

  19. Guo X et al (2018) The posterior pharyngeal wall thickness is associated with OSAHS in patients with acromegaly and correlates with IGF-1 levels. Endocrine 61(3):526–532

    Article  CAS  PubMed  Google Scholar 

  20. Parolin M et al (2020) Obstructive sleep apnea in acromegaly and the effect of treatment: a systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):dgz116

    Article  PubMed  Google Scholar 

  21. Katznelson L et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951

    Article  CAS  PubMed  Google Scholar 

  22. Zhu H et al (2017) Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults. PLOS ONE 12(10):e0185561

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Bonneville JF (2016) Magnetic resonance imaging of pituitary tumors. Front Horm Res 45:97–120

    Article  PubMed  Google Scholar 

  24. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14(6):540–545

    Article  CAS  PubMed  Google Scholar 

  25. Berry R, Rita B, Charlene G (2017) AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med 5(13):665–666

    Article  Google Scholar 

  26. Annamalai AK et al (2013) A Comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 98(3):1040–1050

    Article  CAS  PubMed  Google Scholar 

  27. Tsoy UA et al (2015) Clinical features of sleep-related breathing disorders in patients with acromegaly. Ter Arkh 87(4):47

    Article  CAS  PubMed  Google Scholar 

  28. Senaratna CV et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81

    Article  PubMed  Google Scholar 

  29. Vouzouneraki K et al (2018) Temporal relationship of sleep apnea and acromegaly: a nationwide study. Endocrine 62(2):456–463

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Turan O et al (2018) Airway and sleep disorders in patients with acromegaly. Clin Respir J 12(3):1003–1010

    Article  CAS  PubMed  Google Scholar 

  31. Pivonello R et al (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20(1):46–62

    Article  PubMed  Google Scholar 

  32. Davi’ MV et al (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 159(5):533–540

    Article  CAS  PubMed  Google Scholar 

  33. Bruwier A et al (2011) Acromegaly and sleep apnea: Cephalometric evaluations. Ann Endocrinol 72(3):211–217

    Article  CAS  Google Scholar 

  34. Chennaoui M, Leger D, Gomez-Merino D (2020) Sleep and the GH/IGF-1 axis: consequences and countermeasures of sleep loss/disorders. Sleep Med Rev 49:101223

    Article  PubMed  Google Scholar 

  35. Weiss V et al (2000) Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 23(8):515–519

    Article  CAS  PubMed  Google Scholar 

  36. Horvath E, Kovacs K (2006) Pathology of acromegaly. Neuroendocrinology 83(3–4):161–165

    Article  CAS  PubMed  Google Scholar 

  37. Hochban W et al (1999) Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 14(1):196

    Article  CAS  PubMed  Google Scholar 

  38. Cadieux RJ et al (1982) Endoscopic findings in sleep apnea associated with acromegaly. J Clin Endocrinol Metab 55(1):18–22

    Article  CAS  PubMed  Google Scholar 

  39. Akkoyunlu ME et al (2013) Does hormonal control obviate positive airway pressure therapy in acromegaly with sleep-disordered breathing? Respir Med 107(11):1803–1809

    Article  PubMed  Google Scholar 

  40. Wennberg A et al (2019) Sleep disorders and cognitive dysfunction in acromegaly. Endocrine 66(3):634–641

    Article  CAS  PubMed  Google Scholar 

  41. Choi E et al (2016) The severity of sleep disordered breathing induces different decrease in the oxygen saturation during rapid eye movement and non-rapid eye movement sleep. Psychiatry Investig 13(6):652

    Article  PubMed  PubMed Central  Google Scholar 

  42. Sharma SK et al (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8(1):12–17

    Article  CAS  PubMed  Google Scholar 

  43. Leistner SM et al (2015) Reduced sleep quality and depression associate with decreased quality of life in patients with pituitary adenomas. Eur J Endocrinol 172(6):733–743

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank the sleep technologists (Ruirui Yuan, Juan Wen and Xing Yang) at the Sleep Medicine Center, Tangdu Hospital of the Fourth Military Medical University.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Junying Zhou or Changjun Su.

Ethics declarations

Ethics approval

The Tangdu Hospital Ethics Committee approved this study.

Informed consent

All participants signed informed consent forms before enrollment.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Xianchao Zhao and Lijun Heng are co-first authors of the article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, X., Heng, L., Qu, Y. et al. Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly. Sleep Breath 26, 1381–1387 (2022). https://doi.org/10.1007/s11325-021-02468-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-021-02468-z

Keywords

Navigation